Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sun Pharma Adv Resrc Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SPARC | BSE: 532872

₹199.47

up-down-arrow ₹-3.07 (-1.52%)

As on 04-Sep-2026 15:58IST

Market cap

info icon

₹6,474 Cr

Revenue (TTM)

info icon

₹1,909 Cr

P/E Ratio

info icon

4.1

P/B Ratio

info icon

4.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -97.85 314.11 2,855.80 101.25 84.42
EBIT -102.06 33.46 644.29 103.41 52.18
Net Profit -101.19 59.68 631.12 106.24 51.29
EPS -101.19 59.68 627.01 103.36 46.51
Book Value -- -- 704.47 37.52 53.06
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -312.40-235.0584.1784.54-467.54
Net Margin info -252.26-197.4281.8882.17-465.64
Return on equity info 52.402.69--276.890.00
Return on Capital info -89.82-112.90--163.94-311.92
Return on Assets info -6.44-27.84126.42124.17-80.88
Debt to Equity (x) info ----0.000.42-1.19

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
163.94
-311.92
-112.35
-41.91
Peer Median
--
14.90
14.72
18.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
276.89
--
-121.28
-43.41
Peer Median
10.72
12.77
11.67
14.92
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

126.42

Higher than Peers by 119.84

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
126.42
124.17
-80.88
-57.63
-26.81
Peer Median
6.58
7.09
7.86
9.06
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

84.17

Higher than Peers by 71.57

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
84.17
84.54
-467.54
-548.82
-94.57
Peer Median
12.59
14.07
15.03
14.71
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

81.88

Higher than Peers by 73.11

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
81.88
82.17
-465.64
-368.72
-89.16
Peer Median
8.76
8.54
9.33
8.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
0.00
83.20
-459.99
-496.00
-88.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

2,855.80

Higher than Peers by 2,847.87

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
2,855.80
2,518.47
-5.00
-68.36
--
Peer Median
7.93
13.04
10.27
11.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

647.03

Higher than Peers by 630.51

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
647.03
573.44
19.07
-83.60
--
Peer Median
16.52
17.18
24.15
28.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

631.12

Higher than Peers by 613.87

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
631.12
553.48
11.55
-73.96
--
Peer Median
17.25
24.83
30.29
36.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

627.01

Higher than Peers by 616.69

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
627.01
553.48
11.55
-73.96
--
Peer Median
10.32
17.80
24.50
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
717.12
-272.52
-75.48
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
0.42
-1.19
0.37
0.00
Peer Median
0.04
0.21
0.23
0.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
0.42
-0.73
0.37
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.47

Higher than Peers by 0.73

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
2.47
2.47
0.07
1.02
2.54
Peer Median
1.74
1.83
1.79
1.96
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.47

Higher than Peers by 1.29

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
2.47
2.47
0.07
1.02
2.54
Peer Median
1.18
1.20
1.47
1.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

44.92

Higher than Peers by 37.16

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
44.92
46.50
-36.92
-227.27
-28.15
Peer Median
7.76
8.17
9.42
8.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

0.43

Lower than Peers by 25.31

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
0.43
0.44
22.37
20.56
13.70
Peer Median
25.75
25.14
25.82
26.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.52

Higher than Peers by 0.86

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
1.52
1.50
0.17
0.11
0.29
Peer Median
0.66
0.73
0.75
0.77
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
2.36
80.33
116.55
50.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

4.09

Lower than Peers by 40.89

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
4.09
2.39
--
--
--
Peer Median
44.97
43.99
39.70
33.48
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.91

Higher than Peers by 0.37

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
4.91
2.78
-22.14
95.47
11.36
Peer Median
4.54
4.66
3.72
4.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
--
--
--
--
--
Peer Median
0.10
0.10
0.16
0.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

4.28

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
4.28
2.66
-15.74
-31.93
-28.11
Peer Median
--
29.36
30.23
29.90
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

6,474

Lower than Peers by 1,324

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sun Pharma Adv Resrc
6,474
3,719
4,803
12,006
5,824
Peer Median
7,798
5,258
4,851
2,099
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...